|
Category: pharmaceuticals / chemical synthisis
US / EU / FDA / JECFA / FEMA / FLAVIS / Scholar / Patent Information:
Physical Properties:
| Appearance: | white powder (est) |
| Assay: | 95.00 to 100.00 %
|
| Food Chemicals Codex Listed: | No |
| Melting Point: | 135.00 °C. @ 760.00 mm Hg
|
| Boiling Point: | 321.39 °C. @ 760.00 mm Hg (est)
|
| Vapor Pressure: | 0.000025 mmHg @ 25.00 °C. |
| Flash Point: | 268.00 °F. TCC ( 131.20 °C. ) (est)
|
| logP (o/w): | 1.190 |
| Soluble in: |
| | water, 5295 mg/L @ 25 °C (est) | | | water, 4600 mg/L @ 25 °C (exp) |
Organoleptic Properties:
| |
| Odor and/or flavor descriptions from others (if found). |
| |
| |
Cosmetic Information:
Suppliers:
Safety Information:
| Preferred SDS: View |
| |
| Hazards identification |
| |
| Classification of the substance or mixture |
| GHS Classification in accordance with 29 CFR 1910 (OSHA HCS) |
| None found. |
| GHS Label elements, including precautionary statements |
| |
| Pictogram | |
| |
| Hazard statement(s) |
| None found. |
| Precautionary statement(s) |
| None found. |
| Oral/Parenteral Toxicity: |
oral-child LDLo 104 mg/kg LUNGS, THORAX, OR RESPIRATION: ACUTE PULMONARY EDEMA
BLOOD: HEMORRHAGE
GASTROINTESTINAL: NAUSEA OR VOMITING Lancet. Vol. 2, Pg. 809, 1952.
oral-child TDLo 10 mg/kg/1D-I LUNGS, THORAX, OR RESPIRATION: ACUTE PULMONARY EDEMA
KIDNEY, URETER, AND BLADDER: "CHANGES IN TUBULES (INCLUDING ACUTE RENAL FAILURE, ACUTE TUBULAR NECROSIS)"
KIDNEY, URETER, AND BLADDER: URINE VOLUME DECREASED Clinical Toxicology. Vol. 18, Pg. 247, 1981.
oral-child TDLo 39 mg/kg/13D-I LIVER: "HEPATITIS (HEPATOCELLULAR NECROSIS), DIFFUSE" American Journal of Diseases of Children. Vol. 139, Pg. 453, 1985.
intravenous-dog LD50 681 mg/kg BEHAVIORAL: ANALGESIA Archives Internationales de Pharmacodynamie et de Therapie. Vol. 149, Pg. 571, 1964.
oral-dog LD50 700 mg/kg BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)
LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION Arzneimittel-Forschung. Drug Research. Vol. 21, Pg. 719, 1971.
oral-guinea pig LD50 1075 mg/kg BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)
BEHAVIORAL: TREMOR
BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) Journal of the American Pharmaceutical Association, Scientific Edition. Vol. 47, Pg. 479, 1958.
oral-hamster LD50 3500 mg/kg Archives of Toxicology, Supplement. Vol. 7, Pg. 365, 1984.
oral-human TDLo 480 mg/kg/7D-I BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)
GASTROINTESTINAL: OTHER CHANGES
SENSE ORGANS AND SPECIAL SENSES: TINNITUS: EAR Arzneimittel-Forschung. Drug Research. Vol. 25, Pg. 281, 1975.
oral-human TDLo 669 mg/kg/11D LIVER: LIVER FUNCTION TESTS IMPAIRED American Journal of Hospital Pharmacy. Vol. 35, Pg. 330, 1978.
oral-human TDLo 1050 mg/kg/14D VASCULAR: OTHER CHANGES Clinical Pharmacology and Therapeutics Vol. 67, Pg. 530, 2000.
oral-human TDLo 2880 mg/kg/8W SENSE ORGANS AND SPECIAL SENSES: TINNITUS: EAR
GASTROINTESTINAL: NAUSEA OR VOMITING
GASTROINTESTINAL: DECREASED MOTILITY OR CONSTIPATION Arzneimittel-Forschung. Drug Research. Vol. 33, Pg. 631, 1983.
oral-mammal (species unspecified) LD50 1750 mg/kg Indian Journal of Medical Research. Vol. 81, Pg. 621, 1985.
unreported-man LDLo 294 mg/kg "Poisoning; Toxicology, Symptoms, Treatments," 2nd ed., Arena, J.M., Springfield, IL, C.C. Thomas, 1970Vol. 2, Pg. 73, 1970.
oral-man TDLo 857 mg/kg LUNGS, THORAX, OR RESPIRATION: RESPIRATORY STIMULATION
BEHAVIORAL: COMA Human Toxicology. Vol. 7, Pg. 161, 1988.
oral-man TDLo 1625 mg/kg BEHAVIORAL: COMA Clinical Pediatrics Vol. 24, Pg. 678, 1985.
oral-man TDLo 13036 mg/kg/5Y SKIN AND APPENDAGES (SKIN): "DERMATITIS, OTHER: AFTER SYSTEMIC EXPOSURE"
GASTROINTESTINAL: OTHER CHANGES
MUSCULOSKELETAL: JOINTS Annals of Internal Medicine. Vol. 126, Pg. 665, 1997.
intraperitoneal-mouse LD50 167 mg/kg United States Patent Document. Vol. #4376771
oral-mouse LD50 250 mg/kg Arzneimittel-Forschung. Drug Research. Vol. 5, Pg. 572, 1955.
unreported-mouse LD50 1350 mg/kg United States Patent Document. Vol. #5240918
oral-rabbit LD50 1010 mg/kg BEHAVIORAL: CHANGES IN MOTOR ACTIVITY (SPECIFIC ASSAY) Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. Vol. 24(3), Pg. 43, 1980.
intraperitoneal-rat LD50 340 mg/kg Nippon Yakurigaku Zasshi. Japanese Journal of Pharmacology. Vol. 62, Pg. 11, 1966.
oral-rat LD50 200 mg/kg "Toxicology of Drugs and Chemicals," Deichmann, W.B., New York, Academic Press, Inc., 1969Vol. -, Pg. 67, 1969.
|
| Dermal Toxicity: |
subcutaneous-mouse LD50 1020 mg/kg Chemical and Pharmaceutical Bulletin. Vol. 28, Pg. 1237, 1980.
|
| Inhalation Toxicity: |
|
Not determined
|
Safety in Use Information:
| Category: | pharmaceuticals / chemical synthisis |
| Recommendation for acetyl salicylic acid usage levels up to: | | | not for fragrance use.
|
| |
| Recommendation for acetyl salicylic acid flavor usage levels up to: |
| | not for flavor use.
|
Safety References:
References:
Other Information:
| (IUPAC): | Atomic Weights of the Elements 2011 (pdf) |
| Videos: | The Periodic Table of Videos |
| tgsc: | Atomic Weights use for this web site |
| (IUPAC): | Periodic Table of the Elements |
| CHEBI: | View |
| CHEMBL: | View |
| Golm Metabolome Database: | Search |
| KEGG (GenomeNet): | C01405 |
| HMDB (The Human Metabolome Database): | HMDB01879 |
| FooDB: | FDB000894 |
| Export Tariff Code: | 2918.22.1000 |
| VCF-Online: | VCF Volatile Compounds in Food |
| ChemSpider: | View |
| Wikipedia: | View |
Formulations/Preparations: aspirin formulations:
aspirin formulations:
preparations
dose (mg)
product
manufacturer
pieces, chewing gum
aspergum
heritage, schering plough
tablets
aspirin adult low strength
geri-care,mango-humphries
aspirin low dose
basic viatamins
norwich aspirin
chattem
325 with buffers
magnaprin, improved
rugby
325 with buffers
magnaprin arthritis strength
rugby
norwich aspirin maximum strength
chattem
norwich aspirin maximum strength
chattem
tablets, chewable
bayer children's chewable aspirin
bayer
aspirin childrens
amerisourcebergen, cardinal health, chain drug marketing, eckerd, ivax, major, pdk, prime marketing, qualitest, rugby, url
aspirin for children
geri-care
st. joseph aspirin low strength chewable
mcneil
tablets, delayed-release (enteric-coated)
aspirin adult low strength
amerisourcebergen
aspirin adult low strength
aspirin enteric coated
advance
aspirin low dose
qualitest
aspirin regimen
aspirin regimen low strength
cardinal health
bayer aspirin regimen adult low strength
bayer
ecotrin adult low strength (with propylene glycol)
glaxosmithkline
ecotrin adult low strength (with propylene glycol)
glaxosmithkline
st. joseph adult low strength enteric coated tablets
mcneil
81 with buffers
ascriptin enteric regular strength
novartis
halfprin
kramer
aspirin for arthritis
cardinal health
bayer aspirin regimen regular strength caplets (with propylene glycol
bayer
ecotrin regular strength (with propylene glycol)
glaxosmithkline
genacote
325 with buffers
ascriptin enteric regular strength
novartis
aspirin extra strength
medicine shoppe
aspirin maximum strength
chain drug marketing
ecotrin maximum strength (with propylene glycol)
glaxosmithkline
aspirin delayed release tablets
time-cap, united research
easprin
harvest
tablets, extended-release
zorprin
tablets, film-coated
81 with buffers
women's aspirin plus calcium caplets (with calcium carbonate and crospovidone)
bayer
aspirin lite coated
amerisourcebergen
aspirin microthin coating
cardinal health
bayer aspirin caplets
bayer
genuine bayer aspirin tablets
bayer
325 with buffers
ascriptin regular strength
novartis
325 with buffers
ascriptin arthritis pain caplets
novartis
325 with buffers
bufferin tablets (with povidone and propylene glycol),
novartis consumer health
bayer aspirin extra strength caplets (with propylene glycol)
bayer
bayer aspirin extra strength gelcaplets (with parabens)
bayer
bayer aspirin extra strength tablets
bayer
500 with buffers
ascriptin maximum strength caplets
novartis
500 with buffers
bayer aspirin plus buffered extra strength caplets (with calcium carbonate and propylene glycol)
bayer
500 with buffers
bufferin arthritis strength caplets (with povidone and propylene glycol)
bristol-myers
500 with buffers
bufferin extra strength (with povidone and propylene glycol)
novartis consumer health
tablets, for solution
alka-seltzer effervescent pain reliever and antacid (with citric acid 1 g and sodium bicarbonate 1.916 g)
bayer
alka-seltzer lemon-lime effervescent pain reliever and antacid (with aspartame citric acid 1 g and sodium bicarbonate 1.7 g)
bayer
alka-seltzer extra strength effervescent pain reliever and antacid (with citric acid 1 g and sodium bicarbonate 1.985 g)
bayer
rectal suppositories
aspirin suppositories
consolidated midland
aspirin suppositories
consolidated midland
aspirin suppositories
consolidated midland
aspirin suppositories
consolidated midland, paddock
aspirin suppositories
consolidated midland, paddock
|
Potential Blenders and core components note
Potential Uses:
Occurrence (nature, food, other): note
Synonyms:
| | acesal | | | acesan | | | acetard | | 2- | acetoxybenzenecarboxylic acid | | 2- | acetoxybenzoic acid | | ortho- | acetyl salicylic acid | | | acetyl salicylic acid USP | | 2-( | acetyloxy)benzoic acid | | o-( | acetyloxy)benzoic acid | | 2- | acetyloxybenzoic acid | | o- | acetylsalicylic acid | | ortho- | acetylsalicylic acid | | | acimetten | | | asagran | | | ascriptin | | | aspirdrops | | | aspirin | | | aspirin 20-60 mesh USP | | | aspirin 40-80 mesh USP | | | aspirin USP | | | aspropharm | | | benaspir | | | benzoic acid, 2-(acetyloxy)- | | | cardioaspirina | | | claradin | | | clariprin | | | decaten | | | doril | | | easprin | | | globentyl | | | kapsazal | | | melhoral | | | micristin | | | miniasal | | | pharmacin | | | polopiryna | | | premaspin | | | rhodine NC RP | | | salcetogen | | | salospir | | | solprin | | | tasprin | | | toldex | | | triaminicin |
Articles:
|